TDC
CFRX

Thompson Davis & Co’s ContraFect Corporation CFRX Stock Holding History

Thompson Davis & Co’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-41
Closed -$33K – 774
2017
Q4 		$33K Buy
+41
New +$33.9K 0.08% 242

Other funds holding CFRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Thompson Davis & Co's CFRX Position: Q1 2018 in Review

Thompson Davis & Co sold out of ContraFect Corporation (CFRX) in Q1 2018, closing a stake of 41 shares — an estimated $33K sold.

Thompson Davis & Co first reported a position in CFRX in Q4 2017 and held it in 1 quarter. The position peaked at $33K in Q4 2017. 41 funds tracked by Wall St. Rank hold CFRX as of Q1 2018.

  • Thompson Davis & Co reported no remaining ContraFect Corporation position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 41 ContraFect Corporation shares in Q1 2018, an estimated $33K.
  • Thompson Davis & Co first reported a position in ContraFect Corporation in Q4 2017 and held it in 1 quarter.
  • Thompson Davis & Co's ContraFect Corporation position peaked at $33K in Q4 2017.
  • 41 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.